BIOMAT Database Logo BIOMAT Database Logo

Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections. 1987

R Piccolomini, and L Cellini, and N Allocati, and A Di Girolamo, and G Ravagnan
Istituto di Medicina Sperimentale, Facoltà di Medicina e Chirurgia, Università degli Studi G. D'Annunzio, Chieti, Italy.

We examined 741 urinary tract isolates of the Morganella-Proteus-Providencia group, including the recently defined species Proteus penneri, for susceptibilities to aminoglycosides, semisynthetic penicillins, and cephalosporins. The data emphasize the importance of identification to the species level on the basis of marked species differences in patterns of susceptibility.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011511 Proteus A genus of gram-negative, facultatively anaerobic, rod-shaped bacteria that occurs in the intestines of humans and a wide variety of animals, as well as in manure, soil, and polluted waters. Its species are pathogenic, causing urinary tract infections and are also considered secondary invaders, causing septic lesions at other sites of the body.
D011532 Providencia Gram-negative rods isolated from human urine and feces.
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004755 Enterobacteriaceae A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. Coliform Bacilli,Enterobacteria,Ewingella,Leclercia,Paracolobactrum,Sodalis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection

Related Publications

R Piccolomini, and L Cellini, and N Allocati, and A Di Girolamo, and G Ravagnan
[Antimicrobial susceptibilities of clinical isolates of Morganella-proteus-providencia group of bacteria].
February 1991, The Japanese journal of antibiotics,
R Piccolomini, and L Cellini, and N Allocati, and A Di Girolamo, and G Ravagnan
Population-based study of Morganella-Proteus-Providencia group bloodstream infections.
September 2023, Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada,
R Piccolomini, and L Cellini, and N Allocati, and A Di Girolamo, and G Ravagnan
Production of brownish pigment by bacteria of the Morganella-Proteus-Providencia group.
December 1985, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology,
R Piccolomini, and L Cellini, and N Allocati, and A Di Girolamo, and G Ravagnan
Occurrence and pathogenic role of Morganella-Proteus-Providencia group bacteria in human feces.
February 1986, Journal of clinical microbiology,
R Piccolomini, and L Cellini, and N Allocati, and A Di Girolamo, and G Ravagnan
Prevalence of pathogenic role of Morganella-proteus providencia-group of bacteria in human faeces.
March 1996, African journal of medicine and medical sciences,
R Piccolomini, and L Cellini, and N Allocati, and A Di Girolamo, and G Ravagnan
Antimicrobial activities against biofilm formed by Proteus mirabilis isolates from wound and urinary tract infections.
January 2012, Indian journal of medical microbiology,
R Piccolomini, and L Cellini, and N Allocati, and A Di Girolamo, and G Ravagnan
In vitro activities of antimicrobial agents against Proteus species from clinical specimens.
June 1994, British journal of biomedical science,
R Piccolomini, and L Cellini, and N Allocati, and A Di Girolamo, and G Ravagnan
[Susceptibility of Proteus, Morganella and Providencia strains isolated from patients with urinary tract infections on bactericidal activity of normal human serum].
January 1993, Medycyna doswiadczalna i mikrobiologia,
R Piccolomini, and L Cellini, and N Allocati, and A Di Girolamo, and G Ravagnan
Genetic and biochemical diversity of ureases of Proteus, Providencia, and Morganella species isolated from urinary tract infection.
September 1987, Infection and immunity,
R Piccolomini, and L Cellini, and N Allocati, and A Di Girolamo, and G Ravagnan
Comparative in vitro activity of norfloxacin and seven other antimicrobial agents against clinical isolates from urinary tract infections.
January 1985, Scandinavian journal of infectious diseases,
Copied contents to your clipboard!